<?xml version="1.0" encoding="UTF-8"?>
<p>Several pharmacological reports based on 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> studies have demonstrated that 
 <italic>T. satureioides</italic>, especially its EOs, exhibit various biological activities such as antibacterial [
 <xref rid="B17" ref-type="bibr">17</xref>, 
 <xref rid="B18" ref-type="bibr">18</xref>], antifungal [
 <xref rid="B19" ref-type="bibr">19</xref>, 
 <xref rid="B20" ref-type="bibr">20</xref>], antioxidant [
 <xref rid="B21" ref-type="bibr">21</xref>, 
 <xref rid="B22" ref-type="bibr">22</xref>], antidiabetic [
 <xref rid="B2" ref-type="bibr">2</xref>], anticancer [
 <xref rid="B23" ref-type="bibr">23</xref>], anti-inflammatory [
 <xref rid="B24" ref-type="bibr">24</xref>], insecticidal [
 <xref rid="B25" ref-type="bibr">25</xref>, 
 <xref rid="B26" ref-type="bibr">26</xref>], and hypolipedemic effects [
 <xref rid="B27" ref-type="bibr">27</xref>]. However, the targeted mechanisms of these pharmacological properties have been poorly investigated.
</p>
